CEMMA and LipoCoat Announce Partnership for Coated CVC Catheter
Central Venous Catheter Co-Development
Jasper van Weerd
Bram Pape
April 20, 2022
Introduction
CEMMA Medical and LipoCoat BV announce a co-development partnership for central venous catheters. CEMMA & LipoCoat CVC CollaborationTaipei / Enschede, April 20, 2022 — CEMMA Medical and LipoCoat co-developed a coated Central Venous Catheter (CVC) prototype demonstrating a 2-log reduction in bacterial attachment without antibiotics.
CEMMA & LipoCoat CVC CollaborationTaipei / Enschede, April 20, 2022 — CEMMA Medical and LipoCoat co-developed a coated Central Venous Catheter (CVC) prototype demonstrating a 2-log reduction in bacterial attachment without antibiotics.
Pre-clinical CVC bacterial attachment study data
Jasper van Weerd
CEO / Founder
Jasper van Weerd is CEO of Lipocoat and founder of the LipoCoat coating technology, translating lipid-based science into products that improve the safety, comfort and performance of medical devices.
Bram Pape
Chief Operation Officer
Bram is Chief Operating Officer at Lipocoat, overseeing the operational side of the LipoCoat and SonoCoat coating platforms.
Explore Partnership Opportunities
Connect with our business development team to discuss OEM partnerships and regulatory strategy.
